Upon request from a health technology developer, joint scientific consultations on medical devices may take place in parallel with the consultation with an expert panel designated in accordance with Article 106(1) of Regulation (EU) 2017/745 of the European Parliament and of the Council [Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1, ELI: http://data.europa.eu/eli/reg/2017/745/oj).] (‘expert panel’), pursuant to Article 61(2), of that Regulation (‘the expert panel consultation’). In order for the subgroup on joint scientific consultations of the Coordination Group (‘JSC Subgroup’) to be able to identify the requests for joint scientific consultation to be carried out in parallel with the expert panel consultation, the health technology developer should indicate in the request for joint scientific consultation whether, in parallel, it is requesting the expert panel consultation.
Recital 5, Regulation (EU) 2025/117
In forcesince 24 Jan 2025
Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January…Law
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 Novembe…Law
- celex=31990L0385
- celex=31993L0042
- num:eu=1990/385
- num:eu=1993/42